Today, we are rolling out Medic Mobile’s new tagline: Right tools. Real impact. We hope to succinctly communicate what we do and why – these four words represent an ambitious mission.
Medic Mobile is a nonprofit company using mobile technology to create connected, coordinated health systems that save more lives. At its core, our mission is to improve global health equity by focusing on access and outcomes in low-resource settings. We envision a world where community health workers and patients play an integral role in health systems – new technologies are helping make this vision a reality.
We focus on lowest-common-denominator technologies that health workers and patients actually need. We believe in the importance of lowering barriers to entry and maintenance, enabling new and increased use, and providing the reach necessary to change systems through the “last mile.” Our optimism is rooted in reality, and so is our technology approach.
In order for systems and outcomes to change, someone has to do something differently. The best technology will not have impact unless systems are engineered with an understanding of human behavior – establishing who does what differently, how, when, and why. For each action and each shift in roles, we must map out the conditions (can it happen?) and the incentives (will it happen?) that will lead to progress. Successful system design starts with understanding people at every tier – from patients to policymakers.
The numbers from our pilot study in Malawi show impact – 6 moths, 2x number of TB patients, 2,100 hours saved, $3,000 in fuel saved, 130 patients visited by health professionals. These results provided a platform to replicate and expand our efforts. Working with thousands of health workers and more than 30 international and local partners, we have now established programs in 70% of Malawi’s districts and implemented projects in 12 additional countries in Africa, Asia, and Latin America. The results have continued – stay tuned for promising new data from our programs, from drug stock monitoring to community-level treatment support and prevention of mother-to-child transmission of HIV.
We are now running two randomized, controlled trials studying the impact of our systems – one in India focused on childhood vaccination rates, and a second in Ethiopia examining stock levels at health posts, referral rates for obstetric emergencies, and loss-to-follow-up rates for antenatal clinics.
These impact and cost analyses help make the case for scale, and scale is needed – our full market stands at millions of health workers and hundreds of millions of patients. We will target areas, programs, and users where our impact will be greatest and where system change is most urgently needed. Our goal is to fundamentally shift expectations and realities, even in the most challenging settings.